Patents in the Diagnosis and Therapy of Neurocardiogenic Syncope

Author(s): Anna Kostopoulou, Efthimios G. Livanis, Vassilis Voudris

Journal Name: Recent Patents on Cardiovascular Drug Discovery
Continued as Recent Advances in Cardiovascular Drug Discovery

Volume 4 , Issue 1 , 2009


Neurocardiogenic syncope is one of the most common types of syncope, characterized by arterial vasodilatation with or without bradycardia. The regulation of blood pressure and heart rate is the result of a complex reaction between the central and peripheral nervous system with the circulatory system. Multiple therapies, pharmaceutical and interventional, have been applied without any proven effect. The initial positive reports on pacing were not demonstrated in enough number of controlled studies. Neurocardiogenic syncope continues to remain a clinical problem in terms of understanding its underlying mechanisms and therapy needs to be enlightened by future studies. This article provides a background of diagnosis and therapy of neurocardiogenic syncope and reviews some related patents.

Keywords: Syncope, neurocardiogenic, implanted loop recorders, treatment, pacemakers

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [67 - 71]
Pages: 5
DOI: 10.2174/157489009787259973
Price: $65

Article Metrics

PDF: 38